FDA inspection
Pierre Fabre Medicament: FDA inspection ending Mar 14, 2013
FDA inspection 822697 · No Action Indicated (NAI) · Gaillac
Key facts
| Inspection ID | 822697 |
|---|---|
| Firm | Pierre Fabre Medicament |
| FEI number | 3002807889 |
| Address | Zone Industrielle de Clergous, 16 rue Jean Rostand |
| City | Gaillac |
| Country | France |
| Fiscal year | 2013 |
| Inspection end date | Mar 14, 2013 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data